Home Cart 0 Sign in  

[ CAS No. 573762-62-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 573762-62-6
Chemical Structure| 573762-62-6
Structure of 573762-62-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 573762-62-6 ]

Related Doc. of [ 573762-62-6 ]

Alternatived Products of [ 573762-62-6 ]

Product Details of [ 573762-62-6 ]

CAS No. :573762-62-6 MDL No. :MFCD17010171
Formula : C7H4F3N3 Boiling Point : -
Linear Structure Formula :- InChI Key :WLMSCOVORZUSNW-UHFFFAOYSA-N
M.W : 187.12 Pubchem ID :13532246
Synonyms :

Calculated chemistry of [ 573762-62-6 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 38.36
TPSA : 62.7 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.65 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.98
Log Po/w (XLOGP3) : 1.11
Log Po/w (WLOGP) : 2.71
Log Po/w (MLOGP) : 0.28
Log Po/w (SILICOS-IT) : 1.63
Consensus Log Po/w : 1.34

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.97
Solubility : 1.98 mg/ml ; 0.0106 mol/l
Class : Very soluble
Log S (Ali) : -2.02
Solubility : 1.79 mg/ml ; 0.00956 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.64
Solubility : 0.429 mg/ml ; 0.00229 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.15

Safety of [ 573762-62-6 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 573762-62-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 573762-62-6 ]
  • Downstream synthetic route of [ 573762-62-6 ]

[ 573762-62-6 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 573762-57-9 ]
  • [ 573762-62-6 ]
YieldReaction ConditionsOperation in experiment
91% With iron; acetic acid In ethyl acetate for 15 h; In ethyl acetate (1 ml) and acetic acid (1 ml), a mixture of2-cyano-3- (trifluoromethyl) -5-nitropyridine A10 (0.095 g, 0.44 mmol) and ironpowder (0.112 g, 2 mmol) was heated for 15 hours. The solid particles werefiltered through Celite, the filtrate was concentrated and subjected tochromatography (EtOAc: pentane, 1: 1) to give compound A11 (0.075g, 0.4mmol,91percent).
91% With iron; acetic acid In ethyl acetate for 15 h; Heating Synthesis of 2-cyano-3-(trifluoromethyl)-5-aminopyridine, A11 (0058) A mixture of 2-cyano-3-(trifluoromethyl)-5-nitropyridine A10 (0.095 g, 0.44 mmol) and iron powder (0.112 g, 2 mmol) in ethyl acetate (1 ml) and acetic acid (1 ml) was heated for 15 hours. The solid particle was filtered through Celite and the filtrate was concentrated and chromatographed (EtOAc:pentane, 1:1) to yield compound A11 (0.075 g, 0.4 mmol, 91percent). 1H NMR (400 MHz, CDCl3) δ 6.36 (bs, 2H), 7.38 (d, J=2.4 Hz, 1H), 8.26 (d, J=2.4 Hz, 1H). (0059) Alternatively, 2-cyano-3-(trifluoromethyl)-5-nitropyridine A10 can be reacted with hydrogen over Raney-Ni to obtain 2-cyano-3-(trifluoromethyl)-5-aminopyridine, A11.
67% With iron; acetic acid In ethyl acetate at 65℃; for 2 h; 5-amino-2-cyano-3-trifluoromethylpyridine [0068] 2-cyano-5-nitro-3-trifluoromethylpyridine (7 mg, 0.032 mmol) is dissolved in1 :1 EtOAc/AcOH (1 mL) and heated to 65 0C. Iron powder (9 mg, 0.161 μmol, 5 eq, 325 mesh) is added and the mixture strirred for 2 hours. The mixture is filtered through celite, <n="50"/>and the filtrate is concentrated under vacuo. The crude residue is purified by flash chromatography on silica gel (hexane /EtOAc) to afford 4 mg (67percent) of the desired product. [0069] 1H NMR (400 MHz CDC13) δ 7.20 (d, J = 2.4 Hz, IH), 8.22 (d, J = 2.4 Hz,IH).
54.5% With iron; acetic acid In ethyl acetateReflux Synthesis of 5-amino-3-trifluoromethyl-2-cyanopyridine (Intermediate 5)
To a mixture of compound 4 (1.15 g, 4.9 mmol) in EtOAc (20 mL) and CH3CO2H (4 mL), iron powder (890 mg) was added.
The mixture was refluxed for 16 h before cooling to room temperature.
Then solids were filtered off, followed by washed with ethyl acetate for three times, and the combined organic phases were dried over anhydrous sodium sulfate, the solvent was removed to afford the residue, which was purified by column chromatography to give compound 5 as light brown solid (540 mg, 54.5percent yield).
1H NMR (CDCl3, 400 MHz): δ 8.23 (1H, d, J=2.8 Hz), 7.20 (1H, d, J=2.8 Hz), 4.51 (2H, br) ppm.
54% With iron; acetic acid In ethyl acetate for 16 h; Inert atmosphere; Reflux To a solution of compound 4 (1.15g, 4.9mmoles) in EA (20ml) and AcOH (4ml) was added Fe (890mg) portion-wise under N2 at room temperature. The reaction mixture was refluxed for 16h. After cooling to room temperature, the reaction mixture was filter, then, the filtrate was concentrated under reduced pressure. The residue was purified by flash column chromatography on silics gel (DCM/MeOH=50/1) to afford 5-amino-3-(trifluoromethyl)picolinonitrile (5) (540mg, 54percent). 1H NMR (400 MHz, DMSO-d6) δ 8.21 (d, J=2.8Hz, 1H)7.30 (d, J=2.8Hz, 1H)7.02 (br, 2H). 13C NMR (101 MHz, DMSO-d6) δ 147.97 , 139.37, 129.9 (q, J =30.3 Hz), 122.2 (q, J = 274.7 Hz), 116.0 (d, J = 1.8 Hz), 115.0 (q, J = 4.0 Hz), 112.9.

Reference: [1] Patent: JP2016/11315, 2016, A, . Location in patent: Paragraph 0040; 0047
[2] Patent: US9388159, 2016, B2, . Location in patent: Page/Page column 11; 12; 19
[3] Patent: WO2008/119015, 2008, A2, . Location in patent: Page/Page column 47-48
[4] Patent: US2016/152592, 2016, A1, . Location in patent: Paragraph 0073; 0080; 0081
[5] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 12, p. 2803 - 2806
[6] Patent: US2004/77605, 2004, A1,
[7] Patent: WO2016/100645, 2016, A1, . Location in patent: Page/Page column 22; 23
  • 2
  • [ 956104-45-3 ]
  • [ 573762-62-6 ]
YieldReaction ConditionsOperation in experiment
95% With trifluoroacetic acid In dichloromethane A solution of 2-hydroxy-3-(trifluoromethyl)pyridine C in a mixture of N-iodosuccinimide (NIS), acetonitrile, and dimethylformamide (DMF) is heated at 80° C. for 2 hours to produce 2-hydroxy-3-trifluoromethyl-5-(iodo)pyridine I (greater than 80percent yield). The 2-hydroxy-3-trifluoromethyl-5-(iodo)pyridine I is then mixed with POCl3 in DMF and heated to 130° C. in a microwave for 20 minutes to produce 2-chloro-3-trifluoromethyl-5-(iodo)pyridine J (yield of 50 to 55percent). The 2-chloro-3-trifluoromethyl-5-(iodo)pyridine K is reacted in a solution of pMBnNH2, palladium(II) acetate, 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (BINAP), triethylamine, and cesium carbonate in toluene to produce 5-((4-methoxyphenyl))methylamino)-2-chloro-3-(trifluoromethyl)pyridine K (yield of 40percent). The 5-((4-methoxyphenyl))methylamino)-2-chloro-3-(trifluoromethyl)pyridine K is reacted in a solution of zinc cyanide, tris(dibenzylideneacetone)dipalladium (Pd2(dba)3), and 1,1′-bis(diphenylphosphino)ferrocene (dppf) in DMF to provide 5-(4-methoxybenzylamine)-2-cyano-3-(trifluoromethyl)pyridine K (yield of 92percent). The 5-(4-methoxybenzylamine)-2-cyano-3-(trifluoromethyl)pyridine K is reacted in a solution of dichloromethane and trifluoroacetic acid to provide 2-cyano-3-trifluoromethyl-5-(amino)pyridine H (yield greater than 95percent). The 2-cyano-3-trifluoromethyl-5-(amino)pyridine H is reacted with thiophosgene in water at 25° C. for 2 hours to provide 5-isothiocyanato-3-(trifluoromethyl)pyridine-2-carbonitrile A (yield of 74percent to 95percent).
85% With trifluoroacetic acid In dichloromethane at 20℃; for 2 h; 5-amino-2-cyano-3-trifluoromethylpyridine H: TFA (1 niL) is added dropwise to a solution of pyridine L (83 mg, 0.27 mmol) in dry DCM (0.5 mL) under argon. The solution is stirred overnight at room temperature. After completion of the reaction, the solvent is evaporated and the residue is purified by flash chromatography on silica gel (Hexane/EtOac) to afford the desired product quantitatively. 1H NMR (500 MHz CDC13) δ 7.20 (d, J = 2.4 Hz, IH), 8.22 (d, J = 2.4 Hz,IH).; Scale up and purification of H For the larger scales, an improved process calls for dissolving pyridine L (53 g, 0.172 mol) in TFA/DCM (170 mL, 4:1) at room temperature. Upon reaction completion (approximately 2 hours at room temperature), the volatiles were removed under reduced pressure. The residue is then diluted with EtOAc (800 mL), and washed with saturated aqueous NaHCO3. Vacuum concentration and precipitation from DCM-Hexane (1-2, v-v) gave a relatively clean product. Further washing with DCM gave pure intermediate H as a white solid (27.43 g, 85percent).
Reference: [1] Patent: US9388159, 2016, B2, . Location in patent: Page/Page column 20; 21
[2] Patent: WO2008/119015, 2008, A2, . Location in patent: Page/Page column 51
[3] Patent: WO2011/103202, 2011, A2, . Location in patent: Page/Page column 159
  • 3
  • [ 22245-83-6 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: US2016/152592, 2016, A1,
[2] Patent: US9388159, 2016, B2,
[3] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 12, p. 2803 - 2806
[4] Patent: WO2008/119015, 2008, A2,
  • 4
  • [ 887707-23-5 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: WO2011/103202, 2011, A2,
[2] Patent: US9388159, 2016, B2,
[3] Patent: WO2008/119015, 2008, A2,
  • 5
  • [ 887707-25-7 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: WO2011/103202, 2011, A2,
[2] Patent: US9388159, 2016, B2,
[3] Patent: WO2008/119015, 2008, A2,
  • 6
  • [ 956104-44-2 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: WO2011/103202, 2011, A2,
[2] Patent: US9388159, 2016, B2,
  • 7
  • [ 99368-67-9 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: US9388159, 2016, B2,
[2] Patent: WO2008/119015, 2008, A2,
  • 8
  • [ 99368-66-8 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: WO2016/100645, 2016, A1,
[2] Patent: US2016/152592, 2016, A1,
[3] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 12, p. 2803 - 2806
  • 9
  • [ 3796-23-4 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: JP2016/11315, 2016, A,
[2] Patent: US9388159, 2016, B2,
  • 10
  • [ 22253-72-1 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: JP2016/11315, 2016, A,
[2] Patent: US9388159, 2016, B2,
  • 11
  • [ 406933-21-9 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: JP2016/11315, 2016, A,
[2] Patent: US9388159, 2016, B2,
  • 12
  • [ 99368-66-8 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: US9388159, 2016, B2,
[2] Patent: US9388159, 2016, B2,
  • 13
  • [ 22245-83-6 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: US9388159, 2016, B2,
[2] Patent: US9388159, 2016, B2,
  • 14
  • [ 65753-47-1 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: US9388159, 2016, B2,
[2] Patent: US9388159, 2016, B2,
  • 15
  • [ 99368-68-0 ]
  • [ 573762-62-6 ]
Reference: [1] Patent: US9388159, 2016, B2,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 573762-62-6 ]

Apalutamide Intermediates

Chemical Structure| 887707-25-7

[ 887707-25-7 ]

2-Chloro-5-iodo-3-(trifluoromethyl)pyridine

Chemical Structure| 99368-67-9

[ 99368-67-9 ]

2-Chloro-5-nitro-3-(trifluoromethyl)pyridine

Chemical Structure| 915087-25-1

[ 915087-25-1 ]

4-Amino-2-fluoro-N-methylbenzamide

Chemical Structure| 99368-66-8

[ 99368-66-8 ]

5-Nitro-3-(trifluoromethyl)pyridin-2-ol

Chemical Structure| 22245-83-6

[ 22245-83-6 ]

3-(Trifluoromethyl)pyridin-2-ol

Apalutamide Intermediates

Chemical Structure| 887707-25-7

[ 887707-25-7 ]

2-Chloro-5-iodo-3-(trifluoromethyl)pyridine

Chemical Structure| 99368-67-9

[ 99368-67-9 ]

2-Chloro-5-nitro-3-(trifluoromethyl)pyridine

Chemical Structure| 915087-25-1

[ 915087-25-1 ]

4-Amino-2-fluoro-N-methylbenzamide

Chemical Structure| 99368-66-8

[ 99368-66-8 ]

5-Nitro-3-(trifluoromethyl)pyridin-2-ol

Chemical Structure| 22245-83-6

[ 22245-83-6 ]

3-(Trifluoromethyl)pyridin-2-ol

Related Functional Groups of
[ 573762-62-6 ]

Fluorinated Building Blocks

Chemical Structure| 406933-21-9

[ 406933-21-9 ]

3-(Trifluoromethyl)picolinonitrile

Similarity: 0.89

Chemical Structure| 1214377-57-7

[ 1214377-57-7 ]

5-Bromo-3-(trifluoromethyl)-2-pyridinecarbonitrile

Similarity: 0.79

Chemical Structure| 401590-41-8

[ 401590-41-8 ]

6-Chloro-3-(trifluoromethyl)picolinonitrile

Similarity: 0.75

Chemical Structure| 936841-69-9

[ 936841-69-9 ]

4-(Trifluoromethyl)picolinonitrile

Similarity: 0.74

Chemical Structure| 1000536-10-6

[ 1000536-10-6 ]

2-(4-(Trifluoromethyl)pyridin-2-yl)acetonitrile

Similarity: 0.73

Amines

Chemical Structure| 1187932-68-8

[ 1187932-68-8 ]

(3-(Trifluoromethyl)pyridin-2-yl)methanamine hydrochloride

Similarity: 0.71

Chemical Structure| 1056162-06-1

[ 1056162-06-1 ]

(2-(Trifluoromethyl)pyridin-3-yl)methanamine

Similarity: 0.66

Chemical Structure| 1079054-78-6

[ 1079054-78-6 ]

5-Amino-6-methylpicolinonitrile

Similarity: 0.64

Chemical Structure| 1256806-82-2

[ 1256806-82-2 ]

5-(Methylamino)picolinonitrile

Similarity: 0.63

Chemical Structure| 1121056-94-7

[ 1121056-94-7 ]

5-Nitro-3-(trifluoromethyl)pyridin-2-amine

Similarity: 0.61

Nitriles

Chemical Structure| 406933-21-9

[ 406933-21-9 ]

3-(Trifluoromethyl)picolinonitrile

Similarity: 0.89

Chemical Structure| 1214377-57-7

[ 1214377-57-7 ]

5-Bromo-3-(trifluoromethyl)-2-pyridinecarbonitrile

Similarity: 0.79

Chemical Structure| 401590-41-8

[ 401590-41-8 ]

6-Chloro-3-(trifluoromethyl)picolinonitrile

Similarity: 0.75

Chemical Structure| 936841-69-9

[ 936841-69-9 ]

4-(Trifluoromethyl)picolinonitrile

Similarity: 0.74

Chemical Structure| 1000536-10-6

[ 1000536-10-6 ]

2-(4-(Trifluoromethyl)pyridin-2-yl)acetonitrile

Similarity: 0.73

Trifluoromethyls

Chemical Structure| 406933-21-9

[ 406933-21-9 ]

3-(Trifluoromethyl)picolinonitrile

Similarity: 0.89

Chemical Structure| 1214377-57-7

[ 1214377-57-7 ]

5-Bromo-3-(trifluoromethyl)-2-pyridinecarbonitrile

Similarity: 0.79

Chemical Structure| 401590-41-8

[ 401590-41-8 ]

6-Chloro-3-(trifluoromethyl)picolinonitrile

Similarity: 0.75

Chemical Structure| 936841-69-9

[ 936841-69-9 ]

4-(Trifluoromethyl)picolinonitrile

Similarity: 0.74

Chemical Structure| 1000536-10-6

[ 1000536-10-6 ]

2-(4-(Trifluoromethyl)pyridin-2-yl)acetonitrile

Similarity: 0.73

Related Parent Nucleus of
[ 573762-62-6 ]

Pyridines

Chemical Structure| 406933-21-9

[ 406933-21-9 ]

3-(Trifluoromethyl)picolinonitrile

Similarity: 0.89

Chemical Structure| 1214377-57-7

[ 1214377-57-7 ]

5-Bromo-3-(trifluoromethyl)-2-pyridinecarbonitrile

Similarity: 0.79

Chemical Structure| 401590-41-8

[ 401590-41-8 ]

6-Chloro-3-(trifluoromethyl)picolinonitrile

Similarity: 0.75

Chemical Structure| 936841-69-9

[ 936841-69-9 ]

4-(Trifluoromethyl)picolinonitrile

Similarity: 0.74

Chemical Structure| 1000536-10-6

[ 1000536-10-6 ]

2-(4-(Trifluoromethyl)pyridin-2-yl)acetonitrile

Similarity: 0.73